ISSN 1359-6446
Publisher: Elsevier
all issues | next issue >
Modified transcriptional activators as therapeutic tools pp. 50+52-50+52(1) Author: White J.H.
Automated lead discovery pp. 46-46(1) Author: Wallace R.W.
A pharmaceutical Braveheart - battle lines are drawn pp. 48-48(1) Author: Jack D.B.
Combinatorial biology pp. 48-49(2) Author: Wallace R.W.
New Alzheimer's model from Japan pp. 49-49(1) Author: Jack D.B.
Better use aspirin pp. 49-50(2) Author: Bradley D.
People pp. 52-52(1) Author: Jack D.B.
CAS record pp. 52-52(1) Author: Hughes D.
New approach to drug therapy in Alzheimer's dementia pp. 53-59(7) Authors: Maelicke A.; Albuquerque E.X.
Design and discovery of nonpeptide endothelin antagonists pp. 60-70(11) Author: Doherty A.M.
Squalene synthase inhibitors pp. 82-82(1) Authors: Brown G.R.; Harris G.H.
Acyl-CoA:cholesterol acyltransferase inhibitors pp. 82-82(1) Author: Roth B.D.
Dopamine D3-antagonists and partial agonists pp. 82-82(1) Author: Wright J.
2,4-Diaminopyrrolo-[2,3-d]pyrimidines pp. 83-83(1) Author: Bundy G.L.
Selective 5-HT4 receptor antagonists pp. 83-83(1) Author: Buchheit K.-H.
Stereochemical modulation of pharmacological activity pp. 83-83(1) Author: Brown T.H.
-Alkylated ,-unsaturated amino acids pp. 83-83(1) Authors: Kazmaier U.; Maire S.
N-Acetyl--d mannosamine 1-phosphate analogues pp. 83-83(1) Author: Cipolla L.
Synthesis of pyrrolo [2,3-d]pyrimidines pp. 83-84(2) Authors: Taylor E.C.; Patel H.H.; Jun J.G.
Chiral boron enolates pp. 84-84(1) Authors: Gennari C.; Pain G.; Moresca D.
Michael addition of -sulphinyl and -sulphonyl carbanions pp. 84-84(1) Author: Marco J.-L.
Synthesis of l-(+)-ergothioneine pp. 84-84(1) Authors: Xu J.; Yadan J.C.